Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report
CAGR Value
The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period
This Endocrine...
Roots Analysis recently published a report on the global Digital Biomarkers Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions,...
The landscape of oncology is being redefined by a data-driven approach that prioritizes individualized patient profiles over generic treatment protocols. The Cancer Biomarkers Market Outlook remains exceptionally positive as the medical community integrates molecular insights into standard clinical workflows. With an increasing focus on the early identification of tumor-specific signals,...
Polaris Market Research has introduced the latest market research report titled Genomic Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Disease Indication (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Others); By Validation; By Type; By End-Use; By Region; Segment Forecast, 2021 - 2029 that highlights the major revenue stream for the...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek